
Opinion|Videos|December 19, 2024
Advantages of the Molecular Structure of Aflibercept
Panelists discuss how aflibercept’s molecular structure contributes to its clinical efficacy as a standard treatment for retinal vascular diseases.
Advertisement
Episodes in this series

Video content above is prompted by the following:
- Aflibercept 2 mg is considered the standard of care for retinal vascular diseases. Can you briefly explain the structure of the aflibercept molecule and its significance?
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times Europe
1
AI-predicted retinal function shows promise in geographic atrophy
2
Mulling over options for mitigating severe vision loss from diabetes
3
Demodex blepharitis: Closing the diagnostic gap to improve ocular surface health
4
Review highlights gaps in transition from paediatric to adult eye care
5

























